Mukka Proteins Ltd

Mukka Proteins Ltd

₹ 35.1 0.43%
18 May - close price
About

Incorporated in 2003, It is an animal protein company, primarily engaged in the production of Fish Meal, Fish Oil and Fish Soluble Paste as well as developing alternative proteins such as Black Soldier Fly (BSF) Insect meal in the animal food segment.[1]

Key Points

Leading Fish Meal Manufacturer[1] The company is a leading player in Indian fish protein industry contributing 25-30% to the Indian fish meal and fish oil industry.

  • Market Cap 1,053 Cr.
  • Current Price 35.1
  • High / Low 44.0 / 32.5
  • Stock P/E 16.8
  • Book Value 12.2
  • Dividend Yield 0.00 %
  • ROCE 18.2 %
  • ROE 25.8 %
  • Face Value 1.00

Pros

  • Company has delivered good profit growth of 32.7% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.6%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Sep 2023 Dec 2023 Mar 2024
359 366 315 484 231
339 325 281 472 208
Operating Profit 20 41 34 12 23
OPM % 6% 11% 11% 2% 10%
5 -0 6 8 4
Interest 4 6 6 5 7
Depreciation 1 1 1 1 1
Profit before tax 21 33 33 13 18
Tax % 22% 33% 18% 31% -25%
16 22 27 9 22
EPS in Rs 0.74 1.02 1.23 0.41 0.74
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
407 546 536 693 1,066 1,269
383 526 529 660 1,000 1,187
Operating Profit 25 20 7 33 66 81
OPM % 6% 4% 1% 5% 6% 6%
2 8 9 8 9 20
Interest 4 7 7 8 15 24
Depreciation 2 3 3 4 4 6
Profit before tax 21 19 6 28 55 72
Tax % 25% 32% 24% 30% 28% 12%
15 13 5 20 39 63
EPS in Rs 0.90 1.79 2.09
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 26%
3 Years: 33%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: 33%
3 Years: 190%
TTM: 65%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 25%
3 Years: 29%
Last Year: 26%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 6 6 6 22 22 30
Reserves 40 52 57 60 100 335
81 112 126 162 238 332
70 88 99 84 141 154
Total Liabilities 197 257 288 329 500 851
44 46 49 50 52 60
CWIP 0 1 0 0 0 0
Investments 10 7 12 21 24 34
143 204 228 259 424 757
Total Assets 197 257 288 329 500 851

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-22 -24 -2 -15 -47 -144
-19 2 -5 -7 1 -43
31 23 8 27 61 258
Net Cash Flow -10 0 0 5 15 71

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 22 36 18 28 37 41
Inventory Days 94 68 108 88 87 135
Days Payable 59 58 59 44 49 43
Cash Conversion Cycle 57 47 67 72 75 133
Working Capital Days 69 76 87 89 90 137
ROCE % 15% 6% 16% 23%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2024
73.33%
6.46%
2.00%
18.21%
No. of Shareholders 1,15,928

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents